GW Pharma (GWPH) Said to Hire Advisers Following Approach - Reuters

September 7, 2016 2:48 PM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

(Updated - September 7, 2016 3:02 PM EDT)

GW Pharma (NASDAQ: GWPH) is working with an investment bank following approaches from drug makers that expressed interest in acquiring it, according to Reuters, citing people familiar with the matter.

GW Pharma reportedly hired Morgan Stanley to help handle overtures, and it is not currently interested in exploring a sale. The identity of the potential suitors could not be established.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Hot M&A, Mergers and Acquisitions, Rumors, Trader Talk, Trading Halts

Related Entities

Morgan Stanley

Add Your Comment